Joint‐label fusion brain atlases for dementia research in Down syndrome
暂无分享,去创建一个
N. Tustison | H. D. Rosas | A. Brickman | J. Price | N. Schupf | M. Yassa | D. Keator | D. Nguyen | W. Silverman | M. Mapstone | M. Pulsifer | I. Lott | E. Doran | Julie C. Price | S. Krinsky-McHale | M. Phelan | W. Kreisl | Dana D Nguyen | F. Lai | C. Hom | L. Taylor | D. H. Rosas | N. Queder | N. Tustison | Elizabeth Head | Michael J. Phelan | Nazek Queder | Lisa Taylor | H. Rosas | Julie C Price
[1] Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring announces new editor‐in‐chief for open access, peer reviewed journal , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[2] A. Brickman,et al. Down syndrome: Distribution of brain amyloid in mild cognitive impairment , 2020, Alzheimer's & dementia.
[3] S. Potkin,et al. Brain amyloid and the transition to dementia in Down syndrome , 2020, bioRxiv.
[4] W. Klunk,et al. Neuropathological correlates of amyloid PET imaging in Down syndrome , 2019, Developmental neurobiology.
[5] J. Nunes,et al. Neuroimaging assessment in Down syndrome: a pictorial review , 2019, Insights into Imaging.
[6] A. Danek,et al. Alzheimer's disease in Down syndrome: An overlooked population for prevention trials , 2018, Alzheimer's & dementia.
[7] Sterling C. Johnson,et al. Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation , 2018, Brain Imaging and Behavior.
[8] Justin K. Rajendra,et al. Handling Multiplicity in Neuroimaging Through Bayesian Lenses with Multilevel Modeling , 2017, Neuroinformatics.
[9] Young T. Hong,et al. Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline , 2017, Neurobiology of Aging.
[10] Young T. Hong,et al. The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis , 2017, Neurobiology of Aging.
[11] Amy Lin,et al. Dissociations in Cortical Morphometry in Youth with Down Syndrome: Evidence for Reduced Surface Area but Increased Thickness. , 2016, Cerebral cortex.
[12] Young T. Hong,et al. The pattern of amyloid accumulation in the brains of adults with Down syndrome , 2016, Alzheimer's & Dementia.
[13] J. Hardy,et al. Dementia in Down's syndrome , 2016, The Lancet Neurology.
[14] D. Giavarina. Understanding Bland Altman analysis , 2015, Biochemia medica.
[15] Sterling C. Johnson,et al. Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome. , 2014, Brain : a journal of neurology.
[16] A. Towbin,et al. Imaging findings in Down syndrome , 2014, Pediatric Radiology.
[17] Paul A. Yushkevich,et al. Multi-atlas segmentation with joint label fusion and corrective learning—an open source implementation , 2013, Front. Neuroinform..
[18] N. Schupf,et al. Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia. , 2013, Journal of policy and practice in intellectual disabilities.
[19] Angela Hassiotis,et al. Discrimination and Other Barriers to Accessing Health Care: Perspectives of Patients with Mild and Moderate Intellectual Disability and Their Carers , 2013, PloS one.
[20] W. Silverman,et al. Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis. , 2013, Developmental disabilities research reviews.
[21] M. Mintun,et al. Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods , 2013, The Journal of Nuclear Medicine.
[22] W. Klunk,et al. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B , 2012, Alzheimer's & Dementia.
[23] J. O'Brien,et al. PET imaging of brain amyloid in dementia: a review , 2011, International journal of geriatric psychiatry.
[24] Arno Klein,et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.
[25] R. Kirby,et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. , 2010, Birth defects research. Part A, Clinical and molecular teratology.
[26] Stylianos E. Antonarakis,et al. Down Syndrome: From Understanding the Neurobiology to Therapy , 2010, The Journal of Neuroscience.
[27] A. Dale,et al. One-Year Brain Atrophy Evident in Healthy Aging , 2009, The Journal of Neuroscience.
[28] W. Jagust,et al. Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo , 2009, Behavioural neurology.
[29] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[30] Keith A. Johnson,et al. P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees , 2006, Alzheimer's & Dementia.
[31] H. Hampel,et al. Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease , 2006, Behavior genetics.
[32] N. Schupf,et al. Dementia in adults with mental retardation: assessment at a single point in time. , 2004, American journal of mental retardation : AJMR.
[33] K. Natarajan,et al. Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications. , 2003, Journal of intellectual disability research : JIDR.
[34] A. Dale,et al. Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.
[35] Paul Thompson,et al. Disease-specific probabilistic brain atlases , 2000, Proceedings IEEE Workshop on Mathematical Methods in Biomedical Image Analysis. MMBIA-2000 (Cat. No.PR00737).
[36] D. Brockmeyer. Down Syndrome and Craniovertebral Instability , 1999, Pediatric Neurosurgery.
[37] G D Pearlson,et al. MRI brain changes in subjects with Down syndrome with and without dementia , 1998, Developmental medicine and child neurology.
[38] N. Driesen,et al. Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates , 1995, Neurology.
[39] A. Neuhold,et al. Down syndrome: MR quantification of brain structures and comparison with normal control subjects. , 1991, AJNR. American journal of neuroradiology.
[40] R. S. Williams,et al. A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.
[41] G. Hommel. A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .
[42] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[43] F. Cardemil. Comparison analysis and applications of the Bland-Altman method: correlation or agreement? , 2017 .
[44] G. Dinant,et al. Bmc Family Practice Doctor-patient Communication with People with Intellectual Disability -a Qualitative Study , 2009 .
[45] W. Silverman. Down syndrome: cognitive phenotype. , 2007, Mental retardation and developmental disabilities research reviews.
[46] Nikos Makris,et al. Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.
[47] D. Mann,et al. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease , 2004, Acta Neuropathologica.
[48] M. LeMay,et al. The relationship between enlargement of the temporal horns of the lateral ventricles and dementia in aging patients with Down syndrome , 2004, Neuroradiology.
[49] A. Toga,et al. New approaches in brain morphometry. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[50] S. Sato,et al. Relation of EEG alpha background to cognitive function, brain atrophy, and cerebral metabolism in Down's syndrome. Age-specific changes. , 1990, Archives of neurology.
[51] I. Lott,et al. Dementia in Down's syndrome: observations from a neurology clinic. , 1982, Applied research in mental retardation.